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Summary
Background Infusion therapy is one of the most
frequently prescribed medications in hospitalized pa-
tients. Currently used crystalloid solutes have a vari-
able composition and may therefore influence acid-
base status, intracellular and extracellular water con-
tent and plasma electrolyte compositions and have
a major impact on organ function and outcome. The
aim of our study was to investigate whether use of
acetate-based balanced crystalloids leads to better
hemodynamic stability compared to 0.9% saline.
Methods We performed a sub-analysis of a prospec-
tive, randomized, controlled trial comparing effects of
0.9% saline or an acetate-buffered, balanced crystal-
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loid during the perioperative period in patients with
end-stage renal disease undergoing cadaveric renal
transplantation. Need for catecholamine therapy and
blood pressure were the primary measures.
Results A total of 150 patients were included in the
study of which 76 were randomized to 0.9% saline
while 74 received an acetate-buffered balanced crys-
talloid. Noradrenaline for cardiocirculatory support
during surgery was significantly more often admin-
istered in the normal saline group, given earlier and
with a higher cumulative dose compared to patients
receiving an acetate-buffered balanced crystalloid
(30% versus 15%, p = 0.027; 68 ± 45 µg/kg versus
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weight/min, ±0.002311 versus 0.000107 µg/kg/min,
±0.00039, p = 0.04, respectively). Mean minimum
arterial blood pressure was significantly lower in
patients randomized to 0.9% saline than in patients
receiving the balanced infusion solution (57.2 [SD 8.7]
versus 60.3 [SD 10.2] mmHg, p = 0.024).
Conclusion The use of an acetate-buffered, balanced
infusion solution results in reduced need for use of
catecholamines and cumulative catecholamine dose
for hemodynamic support and in less occurrence of
arterial hypotension in the perioperative period. Fur-
ther research in the field is strongly encouraged.
Keywords Balanced · Crystalloid · Hemodynamic · Re-
nal transplantation · Saline
Introduction
Infusion therapy is one of the most frequently pre-
scribed medications in hospitalized patients. The im-
portance of research on fluid therapy has been un-
recognized for a long time with normal saline being
the most popular infusate [1–4]. During recent years
newer balanced infusates containing lactate or ac-
etate became increasingly popular in many European
countries whereas in the United States 0.9% saline is
still the most widely used infusate in the perioper-
ative and intensive care setting [4]. Currently used
crystalloid solutions have a variable composition and
may therefore influence acid-base status, intracellu-
lar and extracellular water content and plasma elec-
trolyte compositions [5] and have a major impact on
organ function and outcome [6]. Despite continu-
ing evaluation no superiority of one particular type
of fluid has been achieved so far [7–10]. Nonetheless
during recent years it has been shown that the the-
oretically more physiologically balanced buffered in-
fusion solutions may have a respectable advantage in
terms of patient morbidity. A study on healthy human
volunteers found a balanced chloride-reduced infu-
sion solution to be associated with better mean renal
artery flow velocity, renal cortical tissue perfusion and
urine output than infusion of 2 l of 0.9% saline [11].
In a further study including elderly surgery patients,
gastric mucosal perfusion was reduced in patients re-
ceiving 0.9% saline compared to those receiving chlo-
ride-reduced infusion solutions [12]. These data, to-
gether with data from rodents with experimental sep-
sis, which showed significantly lower mean arterial
pressure levels when receiving chloride-rich infusion
solutions compared to lactated Ringer’s, could suggest
an effect of the crystalloid fluid used on a patients’
hemodynamic situation [13].
In the present study we performed a sub-analysis
using data from our previously performed prospec-
tive randomized controlled trial comparing an ac-
etate-buffered balanced infusion solution compared
to 0.9% saline in patients with end-stage renal disease
receiving cadaveric renal transplantation [14]. Our
aim was to investigate whether use of an acetate-
buffered, chloride-reduced balanced infusion solu-
tion would result in A.) less need for catecholamine
use than use of 0.9% saline and B.) in better hemo-




The study was conducted at the Clinic of General
Anesthesiology, Intensive Care and Pain Medicine of
the Medical University of Vienna.
Patients, randomization and study fluids
All patients with end-stage renal disease undergoing
cadaveric renal transplantation were included in the
study. Patients younger than 18 years were excluded
from the study as well as patients with a preoperative
potassium concentration of more than 5.5mmol/l.
Enrollment started on 1 June 2010 and terminated on
28 February 2013. Prior to enrollment the study was
registered at clinicaltrial.org (NCT01075750).
Computer-based randomization was performed at
time of transfer to the preoperative care unit of the
Department of Anesthesiology. Patients either re-
ceived normal saline (osmolality 308mOsm/kg body
weight, base excess –24mmol/l, Na+ 154mmol/L, Cl–
154mmol/L) or a chloride-reduced, acetate-buffered
balanced crystalloid (Elomel Isoton ®, Fresenius Kabi
Austria GmbH, Graz; osmolality 302mOsm/kg, base
excess 0mmol/L, Na+ 140mmol/L, K+ 5mmol/L, Cl–
108mmol/L, Mg++ 1.5mmol/L, Ca++ 2.5mmol/L, ac-
etate 45mmol/L). No intravenous fluid was given
prior to randomization. The following data were ob-
tained from patients: age, sex, height, actual weight,
dry weight, residual daily urine output, number of
prior renal transplantations, total of fluid admin-
istered intraoperatively, total of fluid at start cate-
cholamines, use of catecholamines, dose of cate-
cholamines per kg body weight per min, time on
catecholamines and cumulative vasopressor dose per
kg body weight per min.
Anesthesia
Details on the anesthesia protocol are described else-
where [14]. After intubation patients were fitted with
a central venous line as well as a peripheral venous
line.
Hemodynamic management
Intraoperatively a set infusion rate at 4ml per kg of
ideal body weight per hour (4ml/kg/h) was infused.
Hypotension was defined as a mean arterial pressure
of less than 60mmHg. If hypotension occurred a fluid
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challenge with 250ml of infusate was conducted. Ad-
ditional fluid boluses of 250ml were administered
depending on volume reactivity (increase in mean ar-
terial pressure or/and central venous pressure). If no
reaction to volume challenge was seen a vasopressor
(either phenylephrine or etilefrine) was administered.
A maximum dose of 0.1mg of phenylephrine and
2mg of etilefrine was given at one time. If more than
ten applications of vasopressor were necessary per
hour or likely to exceed ten applications per hour
(severe refractory hypotension) noradrenaline infu-
sion was commenced. Additionally, repeated fluid
boluses were administered if considered necessary by
the anesthesiologist.
Ethics
The study was approved by the local institutional re-
view board (EK 1048/2009 Oct 2009 and EK 1828/2014
Oct 2014, Chairman Prof. E. Singer), of the Medical
University of Vienna, Austria, and registered at a clin-
ical trials registry (NCT01075750). Written informed
consent was obtained from every patient included in
the study.
Statistics
The sample size calculation for the original study is
described in detail elsewhere [14]. Statistical analy-
sis was performed by SPSS version 17.0 (Chicago, IL).
Distribution of interval variables was assessed using
normal plots. Interval variables with a normal distri-
bution are presented as means ± standard deviation
(SD). Non-normally distributed interval variables and
ordinal variables are presented as medians with in-
terquartile ranges (IR). Comparisons of normally dis-
tributed interval variables between the saline group
and the acetate-buffered balanced crystalloid group
were performed using Student’s t-test. Comparisons
of non-normally distributed interval variables and or-
dinal variables between the saline group and the ac-
etate-buffered balanced crystalloid group were per-
Table 1 Baseline characteristicsof patients. Results aremean±standarddeviationormedian (1st–3rdquartile)
Normal saline group Acetate-buffered balanced crystalloid group p-value
Count Percent Count Percent
Sex (male/female) 48/28 63/37 – 47/27 64/36 – 0.99
Age (years) 76 100 56 ± 13 74 100 54 ± 13 0.35
Height (cm) 76 100 173 ± 8 74 100 172 ± 10 0.63
Dry weight (kg) 76 100 80 ± 18 74 100 79 ± 16 0.79
Actual weight (kg) 76 100 81 ± 19 74 100 80 ± 16 0.74
Residual urine output
(ml/24 h)
76 100 500 (0–1000) 74 100 250
(0–1000)
0.45
Prior kidney transplantation 12 16 – 13 118 – 0.36
Non-heart beating kidney
donor
1 1.3 – 2 1.4 – 0.51
Postoperative necessity for
hemodialysis
19 25 – 19 25.7 – 0.49
formed using Mann-Whitney U-test. Comparisons of
categorical variables between the saline group and the
acetate-buffered balanced crystalloid group were per-
formed by the χ2-test.
In order to test whether mean arterial blood pres-
sure differed between the saline group and the ac-
etate-buffered balanced crystalloid group, we used
a generalized estimating equation assuming a normal
probability distribution and a first order exponential
correlation matrix for repeated observations in one
patient. In order to test for differences in the inci-
dence of vasopressor administration between the two
study groups, we used a log-rank test and a Kaplan-
Meier plot for visualization. In order to test whether
vasopressor use was anteceded by hypotension, we
used a Cox regression with vasopressor use as the
dependent variable and mean arterial blood pressure
as the time varying predictor variable. For all analyses
statistical significance was defined by a two-sided P <
0.05.
Figures were drawn using GraphPadPrism 5.01.
Results
A total of 150 patients were included in the study, 76
patients were randomized to normal saline and 74 pa-
tients to an acetate-buffered balanced crystalloid. No
differences between the groups were found for the fol-
lowing parameters: age, sex, height, actual and dry
weight, residual daily urine output, number of prior
renal transplantations. For an overview on baseline
characteristics see Table 1. The CONSORT flow chart
is given in Fig. 1.
In the 0.9% saline group the mean volume of fluid
received during surgery was 1691 ± 664ml com-
pared to 1798 ± 679ml in the balanced acetate-based
infusate group (p = 0.34). Noradrenaline for cardio-
circulatory support during surgery was administered
significantly more often in the normal saline group
compared to patients receiving an acetate-buffered
balanced crystalloid (30% versus 15%, p = 0.027). Pa-
tients receiving normal saline needed noradrenaline
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Fig. 1 ConsolidatedStandardsofReportingTrials (CON-
SORT) flowchart
significantly earlier and the cumulative noradrenaline
dose was significantly higher than patients receiving
an acetate-based crystalloid solute (68min ±45 ver-
sus 75min ±60, p = 0.0055 and 0.000492 µg/kg body
weight/min, ±0.002311 versus 0.000107 µg/kg/min,
±0.00039, p = 0.04, respectively). No difference in
necessity for vasopressor or cumulative dose of vaso-
pressors was seen between the groups (p = 0.47 and
p = 0.08, respectively) (see Table 2; Fig. 2).
Mean minimum arterial blood pressure was signif-
icantly lower in patients randomized to 0.9% saline
than in patients receiving the balanced infusion so-
lution (57.2 [SD 8.7] versus 60.3 [SD 10.2] mmHg;
p = 0.024). Consequently, mean minimum systolic
(77.7 [SD 17.1] versus 80.1 [SD 16.6] mmHg; p =
0.0398) and mean minimum diastolic blood pressure
Table 2 Catecholaminesandvasopressorsneeded in thegroupsstudied (n, percentages,meanandstandarddeviations)
Normal saline group Acetate-buffered balanced crystalloid group P-value
Duration of anesthesia 184 ±73 166 ±77 0.15
Total intraoperative fluid (ml) 1691 ±664 1798 ±679 0.34
Vasopressor 56 73.7% 50 67.6% 0.47
Cumulative vasopressor dose
(µg/kg/min)
0.00011 ±0.00017 0.000083 ±0.000015 0.08
Catecholamines 23 30% 12 15% 0.027
Fluid until vasopressor (ml) 407 ±287 735 ±482 0.007
Time to catecholamines (min) 68 ±45 75 ±60 0.0055
Cumulative catecholamine
dose (µg/kg/min)
0.000492 ±0.002311 0.000107 ±0.00039 0.04
Time on catecholamines (min) 141 74 175 75 0.6
(43.6 [SD 7.2] versus 45.7 [SD 8.6] mmHg; p = 0.0485)
were significantly lower in patients randomized to
0.9% saline. Patients randomized to 0.9% saline over
time had a mean arterial blood pressure, which was
4mmHg lower than in patients receiving an acetate-
buffered balanced solution during whole surgery (95%
CI: 1–7mmHg; p = 0.009). Fig. 3 gives mean and sys-
tolic blood pressure levels during surgery for patients
receiving either 0.9% saline or an acetate-buffered
balanced infusion solution. In the Cox regression
analysis it could be shown that patients receiving cat-
echolamines had significantly lower blood pressure
levels before administration of catecholamines than
patients without catecholamines (see Fig. 4). There
was no difference in heart rate (normal 73 beats
per minute ±12.6 versus acetate-buffered solution
74 beats per minute ±12.2, p = 0.66) and central ve-
nous pressure (normal saline 9 ± 10mmH2O, acetate-
buffered solution 8 ± 5mmH2O, p = 0.34) between the
groups.
Peak chloride levels were significantly higher in
patients randomized to the normal saline group
(109mmol/L [107 to 111] versus 107mmol/L [105
to 109]), p = 0.001 as was fluctuation in serum chlo-
ride levels during surgery (4mmol/L [3 to 6] versus
3mmol/L [2 to 5]), p = 0.03. Serum sodium levels
were not significantly different between the groups
(4mmol/L [3 to 5] versus 3mmol/L [2 to 5]), p = 0.92.
Acid base disturbances are described in more detail
elsewhere [14].
Discussion
These are the first data from a prospective, random-
ized, controlled study comparing the effects of 0.9%
saline and an acetate-buffered balanced crystalloid
solution on hemodynamics in the perioperative pe-
riod. We showed that perioperative use of a balanced
crystalloid as a maintenance fluid is associated with
better hemodynamic stability of patients with end-
stage renal disease receiving cadaveric renal trans-
plantation. These findings are expressed by a sig-
nificantly lower need for use of catecholamines for
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Fig. 2 KaplanMeyer analysis: time to catecholamines
Fig. 3 Mean (upper panel) and systolic (lower panel) blood
pressure levels inpatients receiving either 0.9%salineor an
acetate-bufferedbalanced infusionsolution
hemodynamic support and higher systolic and mean
arterial blood pressure levels.
The strength of the current study is explained by
the study collective: all patients had end-stage renal
disease and received cadaveric renal transplantation.
This collective of patients is especially vulnerable to
Fig. 4 KaplanMeier analysis: probability to neednore-
pinephrine
effects due to infusion solutions since they lack the ca-
pacity of the kidneys to rapidly compensate for elec-
trolyte and acid-base derangements to a variable de-
gree. Theoretically, this makes even slight effects due
to the infusion solution obvious, which would not be
seen in patients with normal kidney function or only
after administration of far larger volumes of fluid.
We found a significantly lower need for cate-
cholamines, a longer time to catecholamines and
a lower cumulative catecholamine dose in the ac-
etate-buffered group. The significantly better hemo-
dynamic stability in patients receiving a balanced
acetate-based infusate compared to normal saline
might be related to A) acetate itself and B) hyper-
chloremia induced by normal saline.
So far no study has compared the hemodynamic ef-
fects of normal saline to an acetate-buffered balanced
crystalloid; however, there is some older evidence
that the use of sodium acetate may have an influ-
ence on the cardiovascular system. In 1978 Liang and
Lowenstein infused acetate and pyruvate in to anes-
thetized dogs to measure their impact on circulation
[15]. They found that increased acetate levels were as-
sociated with a significant increase in cardiac output
[15]. Even though myocardial oxygen consumption
increased during acetate infusion, the decrease in my-
ocardial oxygen uptake and the increase in coronary
sinus blood oxygen saturation suggest that an active
coronary vasodilation which was not a result of the in-
creased cardiac work takes place [15]. Acetate infusion
also increased blood flow to the gastrointestinal tract,
kidneys, intercostal muscles and diaphragm [15]. In
another study by Conahan et al. on resuscitation fluid
composition and myocardial performance during
burn shock in guinea pigs, the authors were able to
show that treatment with Ringer’s acetate significantly
improved cardiac output and contractility when com-
pared to normal saline and Ringer’s lactate [16]. In
the same study Ringer’s acetate was found to have
better blood pressure stabilizing effects compared to
Ringer’s lactate and normal saline [16]. Concerning
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blood pressure stabilization three studies on sodium
acetate found that such an infusion may have a pos-
itive effect on cardiac output but it lowers peripheral
vascular resistance [17–19], a finding that we cannot
confirm; however, it has to be born in mind that data
on acetate and acetate-buffered crystalloid solutes
and hemodynamics remain scarce and are mostly
experimental. There is a lack of controlled random-
ized trials in humans that compare currently available
crystalloid solutes with respect to hemodynamics and
further research certainly should be encouraged.
In 2004 the study group around John Kellum
showed in a model of experimental sepsis that in-
fusion of chloride-rich crystalloids led to a decrease
in arterial blood pressure in rodents compared to
infusion of lactated Ringers [13]. In another cross-
over study on 12 healthy volunteers Chowdhury et al.
found that a colloid, embedded in a balanced crystal-
loid solution, led to increased renal cortical tissue per-
fusion while the same concentration of colloid, em-
bedded in 0.9% saline, did not result in improved renal
perfusion [20]. A similar trial of this group in which 2 l
of 0.9% saline or a chloride-reduced, balanced crystal-
loid was administered to healthy volunteers showed
that administration of 0.9% saline even resulted in
a decline in renal blood flow velocity and renal corti-
cal tissue perfusion [11]. Given this evidence, together
with other recent studies on this subject [2, 21, 22],
it is plausible that hyperchloremia induced by infu-
sion of chloride-rich solutions, is the direct trigger
for unfavorable hemodynamic effects, as seen in our
current study. Only recently, large scale studies and
meta-analysis showed that use of chloride-rich in-
fusion solutions might be associated with adverse
outcome [2, 23, 24]; however, a Cochrane review from
2012 still came to the conclusion that although bal-
anced crystalloids are associated with less occurrence
of hyperchloremia and concurrent metabolic acido-
sis, use of conventional solutions (i. e. 0.9% saline)
can be considered safe in the perioperative period
[25]. Additionally, a recently published randomized
controlled trial comparing 0.9% saline to an acetate-
buffered crystalloid solute found no differences in
terms of acute kidney failure and renal replacement
therapy [26]. Given the current data together with
previously published studies in the field, the need for
prospective randomized controlled trials is obvious.
While studies comparing the currently available crys-
talloid solutes with mortality as the primary endpoint
will be hard to perform due to the large patient num-
bers needed and probable issues with the financing of
such a study, it seems applicable to perform studies
focusing on patient hemodynamics or renal function.
Limitations
Our study has several limitations. The major draw-
back of this study is the lack of invasive hemody-
namic monitoring such as esophagus Doppler, pul-
monary artery catheter or thermodilution techniques.
Additionally, blood pressure was monitored non-in-
vasively, which was performed in order to preserve
blood vessels in patients potentially in need of dial-
ysis shunts in the future. Additionally, it has to be
borne in mind that the original study was designed
to investigate incidence rates of perioperative hyper-
kalemia, other electrolyte and acid-base disorders and
not hemodynamics. Therefore, hemodynamic man-
agement followed hospital standard operating proto-
cols (SOP but not a hemodynamic protocol specially
designed for the present study. Additionally, the study
was not blinded, so investigator bias is possible but
not very likely as hemodynamics were not an out-
come in the first study and hospital SOP’s were fol-
lowed. Nonetheless the results of the present study
should be interpreted with some caution. We see our
results as a first indiction that the choice of crystal-
loid may impact hemodynamic stability, but certainly
further research needs to be done before an overall
conclusion can be reached.
Conclusion
In conclusion, the results of the prospective, random-
ized, controlled trial suggest that use of an acetate-
buffered, balanced infusion solution results in less oc-
currence of arterial hypotension and reduced need for
use of catecholamines and cumulative catecholamine
dose for hemodynamic support in the perioperative
period. The more favorable hemodynamic outcome
of patients receiving an acetate-buffered crystalloid
solute may be attributed to increased cardiac out-
put related to acetate as well as lower susceptibility
for hyperchloremia and concurrent metabolic acido-
sis when compared to normal saline. Future random-
ized, controlled trials are certainly desirable to clarify
the effects of current crystalloid infusates on hemo-
dynamics in the perioperative field and the critically
ill.
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